Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Downgrades Carrier Global to Sector Weight

Keybanc Downgrades Carrier Global to Sector Weight

Keybanc analyst Jeffrey Hammond downgrades Carrier Global (NYSE:CARR) from Overweight to Sector Weight.

byBenzinga Newsdesk

December 13, 2022

1 minute read

Keybanc analyst Jeffrey Hammond downgrades Carrier Global (NYSE:CARR) from Overweight to Sector Weight.

Penn Entertainment Q4 Earnings Highlights: Revenue Miss, EPS Miss, ESPN Bet’s Impact

By Chris Katje

February 15, 11:31 AM

Penn Entertainment stock is falling after missing revenue and EPS estimates in the fourth quarter. A look at the early ESPN Bet launch results and opportunity ahead.

DIS

Analyst Ratings

Where Myriad Genetics Stands With Analysts

By Benzinga Insights

May 4, 5:01 PM

Analysts have provided the following ratings for Myriad Genetics (NASDAQ:MYGN) within the last quarter: Bullish Somewhat Bullish Indifferent…

MYGN

Morgan Stanley Maintains Equal-Weight on ON Semiconductor, Raises Price Target to $89

By Benzinga Newsdesk

February 7, 9:37 AM

Morgan Stanley analyst Joseph Moore maintains ON Semiconductor (NASDAQ:ON) with a Equal-Weight and raises the price target from $70.4 to $89.

Krystal Biotech Gets FDA Nod For Initial-Stage Lung Infection Study

By Ragothaman Srinivasan

August 1, 9:10 AM

The United States Food and Drug Administration (FDA) has accepted Krystal Biotech’ (NASDAQ: KRYS) Investigational New Drug (IND) application to evaluate KB407 in a clinical trial for cystic fibrosis (CF).

KRYS

Keybanc Downgrades Carrier Global to Sector Weight

Related Posts

Penn Entertainment Q4 Earnings Highlights: Revenue Miss, EPS Miss, ESPN Bet’s Impact

Where Myriad Genetics Stands With Analysts

Morgan Stanley Maintains Equal-Weight on ON Semiconductor, Raises Price Target to $89

Krystal Biotech Gets FDA Nod For Initial-Stage Lung Infection Study